BRSYF
Price
$5.49
Change
+$2.09 (+61.47%)
Updated
Aug 12 closing price
Capitalization
295.36M
FSPKF
Price
$20.01
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Capitalization
13.06B
Interact to see
Advertisement

BRSYF vs FSPKF

Header iconBRSYF vs FSPKF Comparison
Open Charts BRSYF vs FSPKFBanner chart's image
Brainsway
Price$5.49
Change+$2.09 (+61.47%)
Volume$199
Capitalization295.36M
Fisher & Paykel Healthcare
Price$20.01
Change-$0.00 (-0.00%)
Volume$970
Capitalization13.06B
BRSYF vs FSPKF Comparison Chart in %
Loading...
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRSYF vs. FSPKF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRSYF is a Hold and FSPKF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (BRSYF: $5.49 vs. FSPKF: $20.01)
Brand notoriety: BRSYF and FSPKF are both not notable
BRSYF represents the Medical/Nursing Services, while FSPKF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BRSYF: 17% vs. FSPKF: 161%
Market capitalization -- BRSYF: $295.36M vs. FSPKF: $13.06B
BRSYF [@Medical/Nursing Services] is valued at $295.36M. FSPKF’s [@Pharmaceuticals: Other] market capitalization is $13.06B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.68B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRSYF’s FA Score shows that 0 FA rating(s) are green whileFSPKF’s FA Score has 0 green FA rating(s).

  • BRSYF’s FA Score: 0 green, 5 red.
  • FSPKF’s FA Score: 0 green, 5 red.
According to our system of comparison, both BRSYF and FSPKF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRSYF’s TA Score shows that 1 TA indicator(s) are bullish while FSPKF’s TA Score has 1 bullish TA indicator(s).

  • BRSYF’s TA Score: 1 bullish, 2 bearish.
  • FSPKF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, FSPKF is a better buy in the short-term than BRSYF.

Price Growth

BRSYF (@Medical/Nursing Services) experienced а 0.00% price change this week, while FSPKF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.04%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +24.44%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Industries' Descriptions

@Medical/Nursing Services (-0.04% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FSPKF($13.1B) has a higher market cap than BRSYF($295M). FSPKF has higher P/E ratio than BRSYF: FSPKF (53.26) vs BRSYF (39.21). BRSYF YTD gains are higher at: 74.286 vs. FSPKF (-0.941). FSPKF has higher annual earnings (EBITDA): 654M vs. BRSYF (8.3M). FSPKF has more cash in the bank: 264M vs. BRSYF (78M). BRSYF has less debt than FSPKF: BRSYF (6.13M) vs FSPKF (153M). FSPKF has higher revenues than BRSYF: FSPKF (1.28B) vs BRSYF (46.1M).
BRSYFFSPKFBRSYF / FSPKF
Capitalization295M13.1B2%
EBITDA8.3M654M1%
Gain YTD74.286-0.941-7,898%
P/E Ratio39.2153.2674%
Revenue46.1M1.28B4%
Total Cash78M264M30%
Total Debt6.13M153M4%
FUNDAMENTALS RATINGS
BRSYF vs FSPKF: Fundamental Ratings
BRSYF
FSPKF
OUTLOOK RATING
1..100
4249
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
7145
PRICE GROWTH RATING
1..100
3658
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRSYF's Valuation (70) in the null industry is in the same range as FSPKF (95). This means that BRSYF’s stock grew similarly to FSPKF’s over the last 12 months.

BRSYF's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for FSPKF (100). This means that BRSYF’s stock grew somewhat faster than FSPKF’s over the last 12 months.

FSPKF's SMR Rating (45) in the null industry is in the same range as BRSYF (71). This means that FSPKF’s stock grew similarly to BRSYF’s over the last 12 months.

BRSYF's Price Growth Rating (36) in the null industry is in the same range as FSPKF (58). This means that BRSYF’s stock grew similarly to FSPKF’s over the last 12 months.

FSPKF's P/E Growth Rating (98) in the null industry is in the same range as BRSYF (100). This means that FSPKF’s stock grew similarly to BRSYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRSYFFSPKF
RSI
ODDS (%)
Bearish Trend 1 day ago
17%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
23%
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
13%
Bullish Trend 1 day ago
46%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
32%
Bullish Trend 1 day ago
50%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
34%
Bullish Trend 1 day ago
46%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
BRSYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FSPKF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DSPIX56.43N/A
N/A
BNY Mellon Instl S&P 500 Stk Idx I
JIBCX68.56N/A
N/A
JHancock Blue Chip Growth 1
BVAOX10.74N/A
N/A
Madison Small Cap Y
MSDUX14.21N/A
N/A
Morgan Stanley Emerging Mkt ex China I
ESCWX11.51N/A
N/A
Embark Small Cap Equity Institutional

BRSYF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRSYF has been loosely correlated with ANSLY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BRSYF jumps, then ANSLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRSYF
1D Price
Change %
BRSYF100%
N/A
ANSLY - BRSYF
61%
Loosely correlated
+13.73%
IOBCF - BRSYF
39%
Loosely correlated
N/A
VERO - BRSYF
30%
Poorly correlated
N/A
WUXIF - BRSYF
27%
Poorly correlated
N/A
SNWV - BRSYF
25%
Poorly correlated
-1.97%
More

FSPKF and

Correlation & Price change

A.I.dvisor tells us that FSPKF and ANSLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FSPKF and ANSLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FSPKF
1D Price
Change %
FSPKF100%
N/A
ANSLY - FSPKF
26%
Poorly correlated
+13.73%
OLYMY - FSPKF
25%
Poorly correlated
+4.87%
TMDX - FSPKF
25%
Poorly correlated
-0.04%
BRSYF - FSPKF
22%
Poorly correlated
N/A
TCHBF - FSPKF
22%
Poorly correlated
N/A
More